Metaiodobenzylguanidine assessment of metastatic neuroblastoma: Observer dependency and chemosensitivity evaluation
- 1 April 2000
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 34 (4) , 237-241
- https://doi.org/10.1002/(sici)1096-911x(200004)34:4<237::aid-mpo1>3.0.co;2-j
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.Journal of Clinical Oncology, 1997
- Metastatic neuroblastoma in children older than one year: Prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring systemCancer, 1996
- Observer variation in the interpretation of bone scintigraphyJournal of Clinical Epidemiology, 1996
- Evaluation of CD44 prognostic value in neuroblastoma: Comparison with the other prognostic factorsEuropean Journal Of Cancer, 1995
- A new 123I-MIBG whole body scan scoring method—Application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastomaEuropean Journal Of Cancer, 1995
- Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation.Journal of Clinical Oncology, 1993
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993
- Neuroblastoma: Effect of genetic factors on prognosis and treatmentCancer, 1992
- I‐131 metaiodobenzylguanidine: Diagnostic use in neuroblastoma patients in relapseMedical and Pediatric Oncology, 1988
- Sequential cisplatin/VM-26 and vincristine/cyclophosphamide/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross-resistant regimen?Journal of Clinical Oncology, 1987